Biotherapeutics News for September 2013

Biotherapeutics News Archive

Innovators working hard to avoid patent exclusions in the US Innovators working hard to avoid patent exclusions in the US

By Adrian Tombling, partner and patent attorney at Withers & Rogers (www.withersrogers.com).Just 18 months after a controversial patent ruling in the US, global pharmaceutical companies and manufacturers of diagnostic methods are working hard to overcome some of the nonsensical exclusions that now apply when seeking commercial protection there.

Shark antibodies could provide key to targeting breast cancer Shark antibodies could provide key to targeting breast cancer

Aberdeen scientists are investigating if antibodies found naturally in sharks could be used to target breast cancer.

UK-Swedish team turn to crowdfunding for promising new QS nanoparticle-based Leukemia treatment UK-Swedish team turn to crowdfunding for promising new QS nanoparticle-based Leukemia treatment

Moreinx DuecomplusA’s project seeks Euros 1 million for DUE-C100 AML candidate